Truist Securities Reiterates Rating on Evolent Health, Inc. $EVH

Key Points

  • Truist Securities now rates Evolent Health, Inc. ($EVH) "buy" with a $7 target.
  • Truist Securities's $7 price target implies 48.78% upside from Evolent Health, Inc.'s ($EVH) current $4.71 share price.
  • The Street's average $EVH price target is $5.77 (Buy).
  • $EVH last traded around $4.71.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Truist Securities reiterated its rating on Evolent Health, Inc. ($EVH) to a "buy" rating in a recent research note and set a price target of $7, a 48.78% upside from the current price.

Evolent Health, Inc. Stock Up 2.3%

Shares of Evolent Health, Inc. ($EVH) traded around $4.71 on Saturday, up 2.3% for the day.

Last price$4.71
Market cap$508.77M
Forward P/E11.51
PEG ratio1.93
Beta0.78
52-week low$2.10
52-week high$10.08
50-day MA$4.76
200-day MA$3.86
Current ratio1.24
Quick ratio1.15
Debt-to-equity2.53

Evolent Health, Inc. Earnings

EPS (ttm)-$4.39
Revenue (ttm)$2.10B
Revenue growth46.90%
Net margin-24.08%
Return on equity-66.97%
Next earningsNov 5, 2026

Analysts Set New Price Targets

ConsensusBuy
Average target$5.77
High target$8
Low target$3
Analysts covering13

About Evolent Health, Inc.

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

ExchangeNYSE
SectorHealthcare
IndustryHealth Information Services
HeadquartersArlington, VA
CEOMr. Seth Barrie Blackley
Employees4,200

Get Evolent Health, Inc. alerts

New 13F filings, insider trades, and analyst moves on $EVH, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.